The Oral C5aR Inhibitor INF904 for the Treatment of Chronic Inflammatory Diseases & Beyond
2:30 pm - Tuesday 2nd December 2025
- INF904 – C5aR inhibitor with best-in-class potential
- C5aR inhibition in Hidradenitis Suppurativa
- C5aR inhibition in Chronic Spontaneous Urticaria